CLU and Alzheimer disease: Subsequently, genome-wide association studies (GWAS) identified a genetic variant in the clusterin gene (CLU) associated with AD (Harold et al., 2009; Lambert et al., 2009), and proteomic studies found clusterin as a biomarker indicative of disease state in the blood (Thambisetty et al., 2010).